THE VISION

Paradigm shift in anastomotic technique

We innovate, manufacture and deliver

a new generation of surgical instruments

for colorectal surgery

 
HISTORY

2006

The start 2006

CarpoNovum is founded by two colorectal surgeons

Anders Grönberg, MD, PhD, engineer, and Prof. Henrik Thorlacius, MD, PhD

Award 2006

CarpoNovum received

Öhrlings Price Water House Coopers and LUIS Innovation awards

2007

Award 2007

CarpoNovum received the award for the most successful company in the Connect Sweden network

Award 2007

CarpoNovum received the national Skapa Development Award

2011

CE 2011

CARP®, predecessor of C-REX®, received CE marking

Developing 2011-2018

C-REX® device family was developed, clinical studies were conducted in Sweden, Denmark and China.

2018

CE 2018

CE mark is warded to the C-REX® portfolio

2020

Scandinavian CCS 2020

A subsidiary of CarpoNovum AB, is formed for surgical education and clinical practice.

 
ABOUT

CarpoNovum is a Swedish company innovating, manufacturing and delivering a new generation of surgical instruments for colorectal surgery.

 

Company’s headquarters, in-house R&D and manufacturing facilities are in Halmstad, Sweden.

 

Scandinavian Centre for Colorectal Surgery, a subsidiary of CarpoNovum, performs all clinical activities, including surgeons' training and accreditation. 
 

 
BOARD OF DIRECTORS
 

Thomas Enckell, Attorney-at-law

Chairman of the Board

Thomas Enckell, chairman of the board, is a lawyer specialized in corporate and real estate law and transactions. He is a member of the Swedish Bar Association and has more than 20 years of experience in M&A and legal issues related to corporate governance. He acts as legal advisor to funds, private equity players and other private companies. Worked at several major Swedish law firms and is founder of Enckell Law Firm. Thomas is board member in a couple of companies in different business areas. 

enkell.png

Jarl Ulf Jungnelius

Member of the Board

Trained as an MD and has previously held leading roles in oncology and clinical development at the pharmaceutical companies Celgene, Takeda, Pfizer, and Eli Lilly. Jarl Jungnelius is currently the CEO of Isofol Medical AB.

jarl.png

Ingrid Atteryd-Heiman

Member of the Board

She has been active in the Life Science industry since 2012 with board work, both as chairman and member. She is currently a member of companies with drug development and medical technology development. She has a degree in economics from Lund University and an MBA in international business from Uppsala University.

ingrid.png

Anders Grönberg

Member of the Board

Engineer, MD Ph.D., and Senior colorectal surgeon. Previously active in Halmstad and Malmö. Founder and CEO of CarpoNovum since 2006. Also, responsible for R&D applying his academic knowledge with a focus on wound healing on the intestine and the development of surgical instruments. Has conducted clinical studies since 2008 in Sweden, Denmark, Germany, and China.

anders.png

Tommy Hedberg

Member of the Board

Senior Advisor in a number of life science companies. Tommy has extensive experience in international marketing and sales, clinical development, and product development in pharmaceuticals and medical technology companies such as Atos Medical, Medscand AB and Janssen Pharma AB. Tommy was the CEO of Atos Medical for 17 years.

tommy.png

Björn Zackrisson

Member of the Board

MD, Ph.D. former CEO for Skånegård Sund, which includes the hospitals in Ängelholm, Helsingborg, Landskrona, and Trelleborg with primary care in the corresponding area. Björn has been a member of the board of Niohundra AB in Norrtälje and Innovation Skåne and has held senior positions within Capio, Praktikertjänst, and Team Olivia.

bjorn.png

Jonas Gulliksson

Member of the Board

Member of the Swedish and US Bar Associations, European Patent Attorney. Founder of the patent law firm Ström & Gulliksson and the law firm Advokatfirman Gulliksson. Former president of Licensing Executives Society International with extensive knowledge in business law, technology transfer agreements, and intellectual property prosecution. Jonas has almost 50 years of experience in national and international patent and intellectual property litigation and arbitration.

jonas.png
 
BOARD OF ADVISORS

Ludvig Arbin

Board of Advisors

Former county councilor in the region of Uppsala, responsible for public healthcare. In the past, Mr. Arbin was chancellor of the Swedish National Office for Cystic Fibrosis and has many years of experience as a consultant in the sphere of public decision-making in the Swedish healthcare system.

ludvig.jpg

Roger Henriksson

Board of Advisors

Professor and senior oncologist at Norrland's University Hospital. Former leader of the regional Cancer Centrum Stockholm Gotland, and of Stockholms oncological clinic, including "Radiumhemmet" at Karolinska University Hospital. Furthermore, Mr. Henriksson has also been chairman of the expert panel advising Stockholm's medicinal committee.

roger henriksson.jpg

Christophe Genetay

Board of Advisors

M.Sc. Civ Eng. and has 25 years experience in the financial industry, working with listed and non-listed companies. Former head of training at the Swedish Council for small investors. Since 2013 been engaged with Investor Relations across various industries.

christophe.jpg

Torbjörn Holm

Board of Advisors

M.D. and professor of surgery at Karolinska Institutet, with colorectal surgery as specialization. Has brought significant contributions to the development of the multi-disciplinary treatment of colorectal cancer in Sweden.

torbjorn_holm.jpg

Gunnar Németh

Board of Advisors

M.D. and professor of orthopedic surgery. Led the Karolinska hospital department for orthopedic surgery and acting subject specialist in Region Stockholm. He since worked with strategic development within Capio, before advancing to CEO for Capio S:t Görans hospital in 2007. Just over a year later, he took over as CEO of the Capio Group. And since 2011 he has been senior advisor across a number of companies.

gunnar_nemeth.jpg

Johan Stein

Board of Advisors

Lecturer and researcher at Stockholm School of Economics for 10 years. He gained a doctorate degree in 2011, later named docent and professor. Has been Head of research and portfolio manager at a number of hedge funds and with Nordea Investment Management. Also has experience from Alfred Berg and BNP Paribas.

johan-stein.jpg
Q&R

Quality and Regulatory

C-REX® devices are CE-marked in Europe. Regulatory approval has been achieved by complying with Medical Device Directive 93/42/EC as Class IIa devices and CarpoNovum holds a certificate of current version of EN ISO 13485.

Quality policy

All team members of CarpoNovum are committed to improve lives of people undergoing colorectal surgery, by providing high-quality, safe and effective products and services that meet our customers’ needs, with focus on continual improvement, by:
 

  • having a close collaboration with leading surgeons and health care professionals

  • complying with all applicable regulatory requirements

  • continually improving the effectiveness of our Quality Management System

  • periodically reviewing the performance of the Quality Management System and our Quality Objectives

  • communicating this Quality Policy to all team members, subcontractors and suppliers to assure that it is understood and implemented